genetherapy.isth.org

Search

All France Foundation Content

Results 1 - 28 of 28

9350-0004_263x1491

Gene Therapy in Hemophilia: Slides

9350-0004_263x1491

Gene Therapy in Hemophilia: Summary and Resources

9350-0004_263x149

Gene Therapy in Hemophilia

9350_isth_micro3

Microlearning: Novel Approaches Under Investigation in Hemophilia

9350_isth_micro2

Microlearning: Neutralizing Antibodies in Hemophilia

9350_isth_micro1

Microlearning: Durability of Gene Therapy in Hemophilia

9278-isth-explore

Hemophilia Gene Therapy: Shared Decision Making - Clinical Companion Guide

9278-isth-explore

Risks and Benefits of Hemophilia Gene Therapy: An EXPLORE Learning Experience

Fundamentals of Diagnosis: SSc-ILD

Updated Follow-up of the Alta Study, Giroctocogene Fitelparvovec (SB-525)

First Data From the Phase 3 HOPE-B Gene Therapy Trial

The World Federation of Hemophilia Gene Therapy Registry

Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Pipe)

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Leebeek)

AMT-060 Gene Therapy in Adults With Severe or Moderate-Severe Hemophilia B (Miesbach)

First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology

Characterisation of Adeno-Associated Virus Vector Persistence

Follow-up on a Novel Adeno-Associated Virus (AAV) Gene Therapy (FLT180a)

Etranacogene Dezaparvovec, an Enhanced Vector for Gene Transfer in Adults (Drygalski)

Efficacy and Safety of Etranacogene Dezaparvovec in Adults

Key Considerations: Advances in Gene Therapy for Hemophilia

The Safety of Hemophilia Gene Therapy Now and in the Future

Viral Vectors Gene Therapy Podcasts

WFH Gene Therapy Registry

HTC Readiness: A Multidisciplinary Perspective

HTC Readiness: A Global Perspective

Gene Therapy: Patient Support, Patient Counseling, and Monitoring

Gene Therapy: Update on Efficacy of Clinical Trials

The France Foundation

A ACCME Accredited provider.

The France Foundation ©

10 Vista Drive, Old Lyme, CT USA